Allarity Therapeutics Insider Trades
NASDAQ: ALLRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Allarity Therapeutics insider activity
Over the last 12 months, Allarity Therapeutics insiders reported 6 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Jensen Thomas (CEO) reporting a transaction in 200,000 shares on Jan 28, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ALLR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ALLR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 28, 2026 | Graff Jeremy R.See Remarks | Award | 133,333 | — | Form 4 |
| Jan 28, 2026 | Ervin Jeffrey SCFO | Award | 150,000 | — | Form 4 |
| Jan 28, 2026 | McLaughlin Gerald W.Director | Award | 45,000 | — | Form 4 |
| Jan 28, 2026 | Jensen ThomasCEO | Award | 200,000 | — | Form 4 |
| Jan 7, 2026 | Graff Jeremy R.See Remarks | Award | 133,333 | — | Form 4 |
| Jan 7, 2026 | Hoeiland JesperDirector | Award | 25,000 | — | Form 4 |
| Sep 30, 2025 | Graff Jeremy R.See Remarks | Tax withholding | 14,613 | $23.09K | Form 4 |
| Sep 30, 2025 | Graff Jeremy R.See Remarks | Option exercise | 39,494 | — | Form 4 |
| Jan 22, 2025 | Jensen ThomasCEO | Award | 396,734 | — | Form 4 |
| Jan 22, 2025 | Epshinsky AlexanderCFO | Award | 29,496 | — | Form 4 |
| Jan 22, 2025 | Graff Jeremy R.CDO | Award | 144,441 | — | Form 4 |
| Sep 30, 2024 | Graff Jeremy R.See Remarks | Award | 118,483 | $250.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4